Quest Diagnostics Says Evaluating Opportunities To Scale Lab Testing Capacity And Rapid Antigen Test Inventory Should COVID-19 Test Demand Increase; Says Has Performed And Reported Over 55.5M Molecular Diagnostic And Antibody Serology Tests Since 2020

-Reuters

byBill Haddad

September 14, 2021

1 minute read

-Reuters

BridgeBio Partnered Protein Replacement Therapy Shows Promising Action In Painful Skin Blistering Disorder

By Vandana Singh

Today, 10:51 AM

BridgeBio Pharma Inc (NASDAQ:BBIO) and affiliate company Phoenix Tissue Repair announced data from the Phase 2 trial of PTR-01 in recessive…

BBIO

MediciNov’s MN-166 Reduces Odds Of Heavy Drinking by 45% After 14 Days Of Treatment

By Vandana Singh

Today, 10:51 AM

MediciNov Inc (NASDAQ:MNOV) has announced that positive results from a Phase 2 trial of MN-166 (ibudilast) in alcohol use…

MNOV

Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications

By Vandana Singh

Today, 10:51 AM

Sarepta Therapeutics Inc (NASDAQ:SRPT) will license a new group of adeno-associated viruses from the institute for undisclosed upfront payment and milestone…

SRPT

Elon Musk Activates 100 Starlinks In Iran After Government Blocks Internet Access Amid Protests

By Navdeep Yadav

Today, 10:51 AM

SpaceX Chief Executive Elon Musk announced that his company is now close to having 100 Starlink satellite internet…

TSLA

Quest Diagnostics Says Evaluating Opportunities To Scale Lab Testing Capacity And Rapid Antigen Test Inventory Should COVID-19 Test Demand Increase; Says Has Performed And Reported Over 55.5M Molecular Diagnostic And Antibody Serology Tests Since 2020

Related Posts

BridgeBio Partnered Protein Replacement Therapy Shows Promising Action In Painful Skin Blistering Disorder

MediciNov’s MN-166 Reduces Odds Of Heavy Drinking by 45% After 14 Days Of Treatment

Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications

Elon Musk Activates 100 Starlinks In Iran After Government Blocks Internet Access Amid Protests